flow trial semaglutide kidney outcomes hazard ratio 0.76 and Survival Benefits of in Diabetes With Chronic Kidney Disease: Cardiovascular Subgroup Analyses In the FLOW trial, researchers

When caught early, pernicious anemia can often be effectively managed, helping to reverse symptoms and restore your health

NSAIDs like naproxen can impair kidney function, particularly in patients with pre-existing renal disease, dehydration, or those taking other nephrotoxic medications

[3] Hypotension

genetic testing may help optimize subsequent therapy selection based on individual GLP-1 pathway predispositions

Weight reduction was accompanied by improvements in glycemic control and cardiometabolic markers

Combined measurement of the Higgs Boson Mass in pp collisions at sqrt[s]=7 and 8 TeV with the ATLAS and CMS experiments